Show Filters

Searches all publications.

Search Fulltext



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-06-23
    E.g., 2018-06-23


12160 items
10:11 AM, Jun 13, 2018  |  BC Extra | Financial News

Immunomedics raises $276M on heels of BLA submission

Immunomedics Inc. (NASDAQ:IMMU) raised $276 million through the sale of 11.5 million shares at $24 in a follow-on underwritten by Morgan Stanley, Cowen, Jefferies and Wells Fargo Securities. The offering price is just above Immunomedics'...
2:13 PM, Jun 12, 2018  |  BC Extra | Financial News

Alta closes $130M fund for biotechs, tech-based healthcare services

Alta Partners closed its Alta Partners NextGen Fund I at $130 million to invest in biotech and healthcare delivery companies. Alta told BioCentury the fund will invest in about six to eight companies. Alta has made...
1:20 PM, Jun 12, 2018  |  BC Extra | Financial News

Kadmon raises $100M ahead of new trials

Kadmon Holdings Inc. (NYSE:KDMN) added $0.35 (10%) to $3.68 on Tuesday after it raised $100 million in two offerings through the sale of 30.3 million shares at $3.30. The company sold the shares in a...
2:27 PM, Jun 11, 2018  |  BC Extra | Financial News

Juvenescence raises $50M series A

Juvenescence Ltd. (Douglas, Isle of Man) raised $50 million on Monday in an oversubscribed series A round from founders, insiders, institutional investors and family offices. Juvenescence creates or invests in new companies to develop aging...
7:04 AM, Jun 11, 2018  |  BC Extra | Financial News

WuXi AppTec, Insilico enter R&D, equity deal

WuXi AppTec Co. Ltd. (Shanghai:603259) led a venture round for Insilico Medicine Inc. (Baltimore, Md.) and partnered with the artificial intelligence company to discover and develop new molecules. Insilico CEO Alex Zhavoronkov told BioCentury it raised...
3:43 PM, Jun 08, 2018  |  BC Extra | Financial News

ABL snags $65M in series C

ABL Bio Inc. (Seongnam, South Korea) raised $65 million in a series C round led by new investors DS Asset Management, Alpen Route Asset Management, Quad Asset Management and Hana Financial Investment. ABL has now...
12:14 PM, Jun 08, 2018  |  BC Extra | Financial News

TapImmune shares climb on $70M offering

TapImmune (NASDAQ:TPIV) jumped $3.05 (51%) to $9 Friday after it priced a $70 million private placement led by new investor New Enterprise Associates. The company is selling 17.5 million shares at $4. New investors Aisling...
6:09 AM, Jun 08, 2018  |  BC Extra | Financial News

Autolus proposes IPO terms

Cell therapy developer Autolus Therapeutics Ltd. (London, U.K.) revealed terms for its proposed IPO on NASDAQ. In a regulatory filing Friday, the company proposed to sell 7.8 million ADSs at $15-$17, with each ADS representing...
5:47 AM, Jun 08, 2018  |  BC Extra | Financial News

MeiraGTx trades flat after $75M IPO

Gene therapy play MeiraGTx Holdings plc (NASDAQ:MGTX) shares were unchanged Friday after the company raised $75 million via the sale of 5 million shares at $15 in an IPO underwritten by BofA Merrill Lynch, Barclays,...
4:31 PM, Jun 07, 2018  |  BC Extra | Financial News

Gimv hires Vanparys as partner

Bram Vanparys joined Gimv's life sciences team as a partner. He was director at Merck Ventures....